Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis. Arch Ital Urol Androl. 2015;87(2):121-129. doi:10.4081/aiua.2015.2.121